Vivek Subbiah: The world famous lung cancer gurus

Vivek Subbiah shared on X:

“The world famous lung cancer gurus just arrived from San Diego from world lung meeting. So many advances in lung cancer that practice changes every week and many of them within these 2 weeks.”

Source: Vivek Subbiah/X

More posts featuring Vivek Subbiah on oncodaily.com

Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer.

He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials.